HEART 诊疗路径对综合医疗体系内胸痛管理的影响
本研究为前瞻性中断时间序列研究,纳入 65,393 例因疑似急性冠脉综合征就诊的成人急诊 encounters(实施前 30,522 例,实施后 34,871 例)。主要结局为 30 天内住院或观察、非侵入性负荷试验或两者兼有,实施后调整后比值比为 0.984(95%CI 0.974 至 0.995),对应 12 个月随访后调整后月度绝对下降 4.39%(95%CI 3.72% 至 5.07%),且呈持续下降趋势。30 天全因死亡或急性心肌梗死无差异(实施前 0.6% vs 实施后 0.6%;OR 1.02;95%CI 0.97 至 1.08)。结论认为 HEART 路径减少了住院医疗和非侵入性心脏检查,且安全。
要点
- 实施 HEART 路径后,30 天内住院或观察、非侵入性负荷试验或两者的调整后 OR 为 0.984(95%CI 0.974 至 0.995)。
- 12 个月随访后,主要结局调整后月度绝对下降 4.39%(95%CI 3.72% 至 5.07%),并呈持续下降趋势。
- 30 天全因死亡或急性心肌梗死实施前 0.6% vs 实施后 0.6%,OR 1.02(95%CI 0.97 至 1.08),无差异。
- 总体 33.5% 的急诊胸痛 encounters 发生主要结局(实施前 35.5% vs 实施后 31.8%)。
- 作者认为使用 HEART 对胸痛患者进行风险分层可提高诊疗效率和质量。
适用人群与场景
- 成人因疑似急性冠状动脉综合征在社区急诊就诊的 encounters。
研究设计与关键结果
- 研究类型为前瞻性中断时间序列研究,纳入 65,393 例急诊 encounters(实施前 30,522 例,实施后 34,871 例)。
- 主要结局为 30 天内住院或观察、非侵入性负荷试验或两者兼有,实施后调整后 OR 0.984(95%CI 0.974 至 0.995)。
- 12 个月随访后主要结局调整后月度绝对下降 4.39%(95%CI 3.72% 至 5.07%),呈持续下降趋势。
- 30 天全因死亡或急性心肌梗死实施前 0.6% vs 实施后 0.6%,OR 1.02(95%CI 0.97 至 1.08)。
- 总体 33.5% 的急诊胸痛 encounters 发生主要结局(实施前 35.5% vs 实施后 31.8%)。
证据类型、等级与局限
- 证据类型为前瞻性中断时间序列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在社区急诊对疑似急性冠脉综合征的成人胸痛患者实施 HEART 路径,与住院或观察及非侵入性负荷试验减少相关,且 30 天死亡或心梗无差异。
- 作者认为使用 HEART 对胸痛患者进行风险分层可提高诊疗效率和质量。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
STUDY OBJECTIVE: We describe the association of implementing a History, ECG, Age, Risk Factors, and Troponin (HEART) care pathway on use of hospital care and noninvasive stress testing, as well as 30-day patient outcomes in community emergency departments (EDs).
METHODS: We performed a prospective interrupted-time-series study of adult encounters for patients evaluated for suspected acute coronary syndrome. The primary outcome was hospitalization or observation, noninvasive stress testing, or both within 30 days. The secondary outcome was 30-day all-cause mortality or acute myocardial infarction. A generalized estimating equation segmented logistic regression model was used to compare the odds of the primary outcome before and after HEART implementation. All models were adjusted for patient and facility characteristics and fit with physicians as a clustering variable.
RESULTS: A total of 65,393 ED encounters (before, 30,522; after, 34,871) were included in the study. Overall, 33.5% (before, 35.5%; after, 31.8%) of ED chest pain encounters resulted in hospitalization or observation, noninvasive stress testing, or both. Primary adjusted results found a significant decrease in the primary outcome postimplementation (odds ratio 0.984; 95% confidence interval [CI] 0.974 to 0.995). This resulted in an absolute adjusted month-to-month decrease of 4.39% (95% CI 3.72% to 5.07%) after 12 months' follow-up, with a continued trend downward. There was no difference in 30-day mortality or myocardial infarction (0.6% [before] versus 0.6% [after]; odds ratio 1.02; 95% CI 0.97 to 1.08).
CONCLUSION: Implementation of a HEART pathway in the ED evaluation of patients with chest pain resulted in less inpatient care and noninvasive cardiac testing and was safe. Using HEART to risk stratify chest pain patients can improve the efficiency and quality of care.
参考来源
- Sharp AL, Baecker AS, Shen E, et al. Effect of a HEART Care Pathway on Chest Pain Management Within an Integrated Health System. Ann Emerg Med. 2019. PMID: 30797573. doi:10.1016/j.annemergmed.2019.01.007
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。